0001140361-24-008177.txt : 20240215
0001140361-24-008177.hdr.sgml : 20240215
20240215160600
ACCESSION NUMBER: 0001140361-24-008177
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231130
FILED AS OF DATE: 20240215
DATE AS OF CHANGE: 20240215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ANDREEFF DANE
CENTRAL INDEX KEY: 0001201810
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38445
FILM NUMBER: 24643807
MAIL ADDRESS:
STREET 1: C/O ANDREEFF EQUITY ADVISORS L.L.C.
STREET 2: 140 E. ST. LUCIA LANE
CITY: SANTA ROSA BEACH
STATE: FL
ZIP: 32459
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HELIUS MEDICAL TECHNOLOGIES, INC.
CENTRAL INDEX KEY: 0001610853
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 364787690
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 642 NEWTOWN YARDLEY ROAD
CITY: NEWTOWN
STATE: PA
ZIP: 18940
BUSINESS PHONE: 215-944-6100
MAIL ADDRESS:
STREET 1: 642 NEWTOWN YARDLEY ROAD
CITY: NEWTOWN
STATE: PA
ZIP: 18940
FORMER COMPANY:
FORMER CONFORMED NAME: HELIUS MEDICAL TECHNOLOGIES, INC
DATE OF NAME CHANGE: 20180517
FORMER COMPANY:
FORMER CONFORMED NAME: HELIUS MEDICAL TECHNOLOGIES, INC.
DATE OF NAME CHANGE: 20140613
4/A
1
form4.xml
FORM 4/A
X0508
4/A
2023-11-30
2023-12-04
0001610853
HELIUS MEDICAL TECHNOLOGIES, INC.
HSDT
0001201810
ANDREEFF DANE
C/O HELIUS MEDICAL TECHNOLOGIES, INC.
642 NEWTOWN YARDLEY ROAD, SUITE 100
NEWTOWN
PA
18940
true
true
true
President and CEO
false
Common Stock
2023-11-30
4
P
0
641
6.3704
A
1239
I
See footnote
Common Stock
2023-12-01
4
P
0
643
6.448
A
1882
I
See footnote
Common Stock
9991
I
See footnote
Common Stock
13684
I
See footnote
Common Stock
29
D
On December 4, 2023, the reporting person filed a Form 4 (the "Original Form 4") which incorrectly reported that these shares were purchased by Maple Leaf Discovery I, LP ("MLD I"), when in fact they were purchased by Maple Leaf Offshore, Ltd. ("MLO"). This amendment is being filed to correctly reflect the purchases and the amount of shares held by both MLD I and MLO following the reported transactions.
As a result of a rounding error following a reverse stock split by the Issuer, the Original Form 4 incorrectly stated the amount of securities beneficially owned. The amounts reported on this amendment have been corrected to reflect the actual number of shares held at the time of filing the Original Form 4.
The shares are held by MLO. The reporting person is the president of the managing member of Andreeff Equity Advisors, L.L.C., the investment manager of MLO and as such may be deemed to beneficially own the securities owned by MLO. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
The shares are held by MLD I. The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I and as such may be deemed to beneficially own the securities owned by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
/s/ Dane Andreeff
2024-02-15